Speaker

Thomas Ormsby

Associate Professor, University of Massachusetts Medical School

Thomas Ormsby, Associate Professor at University of Massachusetts Medical School, is speaking at 2nd Oligonucleotide-Based Therapeutics Summit (Boston, United States of America, 8–10 Dec 2026) in the session “Enabling Targeted Muscle Delivery Through Aptamer-siRNA Conjugates Beyond Antibody Conjugates”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd Oligonucleotide-Based Therapeutics Summit
8–10 Dec 2026Boston, United States of America
- SpeakerEnabling Targeted Muscle Delivery Through Aptamer-siRNA Conjugates Beyond Antibody Conjugates
- SpeakerRoundtable Discussion: Is Transferrin Receptor Targeting Still the Future of Delivery?

More speakers at 2nd Oligonucleotide-Based Therapeutics Summit

Julia Alterman
Assistant professor, University of Massachusetts Medical School
Sayantan Chatterjee
Oligonucleotide Chemistry Scientist, Korro Bio
Seymour de Picciotto
CEO, Cellado
Shuhan Huang
Scientist, WYSS
Cecilia Leung
VP of Research, Vivatides Therapeutics
Stephanie Maiocco
VP of Biotherapeutics, Evercrisp

See all 8 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Thomas Ormsby, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].